Redhill Biopharma (RDHL) news
Recent news
Info Edge Board OKs ~INR 1B investment in unit 5IHL
Info Edge (India) Limited has approved an investment of approximately INR 1 billion in its subsidiary, 5IHL, as part of its strategic capital allocation plans. The investment, approved by the company’s board of directors, is intended to support the subsidiary’s operational requirements and to…
AInvest Wire · 2d agoNew deal: Apotex min. C$1B debt offering in three parts
Apotex Health Corp. has announced a minimum C$1 billion debt offering, structured in three parts, to address its financial obligations and support ongoing operations. This move comes amid a challenging financial landscape for the pharmaceutical company, which reported net loss of $38.3 million , a…
AInvest Wire · Sep 28, 2026Redhill Biopharma - Pays $12 mln upfront for commercialization rights plus potential milestones and royalties
AInvest Wire · Sep 1, 2026Redhill Biopharma - Buys exclusive global and U.S. commercialization rights to Rebyota and Clenpiq
RedHill Biopharma Ltd. (Nasdaq: RDHL) has announced the acquisition of exclusive global and U.S. commercialization rights to two medical food products, Rebyota and Clenpiq, from Entera Health. This move expands RedHill’s portfolio in the gastrointestinal and infectious disease markets, aligning…
AInvest Wire · Sep 1, 2026Redhill Biopharma - Apotex to pay $18 mln upfront plus up to $35 mln in worldwide net sales milestones
AInvest Wire · Aug 31, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.